Lead Exposure and Prevention Advisory Committee (LEPAC), 16003 [2022-05801]
Download as PDF
<![CDATA[
Federal Register / Vol. 87, No. 54 / Monday, March 21, 2022 / Notices
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Lead Exposure and Prevention
Advisory Committee (LEPAC)
Centers for Disease Control and
Prevention (CDC), Department of Health
and Human Services (HHS).
ACTION: Notice of meeting.
AGENCY:
In accordance with the
Federal Advisory Committee Act, the
CDC announces the following meeting
for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This is a
virtual meeting and is open to the
public. Advance registration by April
28, 2022, is needed to receive the
information to join the meeting. The
registration link is provided in the
ADDRESSES section below.
DATES: The meeting will be held on May
12, 2022, from 9:00 a.m. to 4:30 p.m.,
EDT.
SUMMARY:
Register in advance at
https://www.zoomgov.com/webinar/
register/WN_
JpapSgFXRKmeHVU9hW4jVQ to
receive information to join the meeting.
FOR FURTHER INFORMATION CONTACT:
Alexis Pullia, M.P.H., C.P.H., Committee
Management Specialist, National Center
for Environmental Health, CDC, 4770
Buford Highway, Atlanta, Georgia
30341, Telephone: 770–488–3300;
Email: LEPAC@cdc.gov.
SUPPLEMENTARY INFORMATION:
Background: The Lead Exposure and
Prevention Advisory Committee was
established under Section 2203 of
Public Law 114–322, the Water
Infrastructure Improvements for the
Nation Act; 42 U.S.C. 300j-21, Registry
for Lead Exposure and Prevention
Advisory Committee.
Purpose: The LEPAC is charged with
providing advice and guidance to the
Secretary, Department of Health and
Human Services (HHS), and the
Director, CDC and Administrator,
ATSDR, on (1) reviewing Federal
programs and services available to
individual communities exposed to
lead; (2) reviewing current research on
lead exposure to identify additional
research needs; (3) reviewing and
identifying best practices, or the need
for best practices regarding lead
screening and the prevention of lead
poisoning; (4) identifying effective
services, including services relating to
healthcare, education, and nutrition for
individuals and communities affected
by lead exposure and lead poisoning,
khammond on DSKJM1Z7X2PROD with NOTICES
ADDRESSES:
VerDate Sep<11>2014
21:01 Mar 18, 2022
Jkt 256001
including in consultation with, as
appropriate, the lead exposure registry
as established in Section 2203(b) of
Public Law 114–322; and 5) undertaking
any other review or activities that the
Secretary determines to be appropriate.
Matters To Be Considered: The agenda
will include updates on the Flint Lead
Registry and lead-related activities from
LEPAC Members; information on lead
exposure in Clarksburg, West Virginia;
and discussions on the following:
Infrastructure initiatives related to lead;
lead in air, soil, and blood; navigating
multiple funding streams at the local
level; and policy approaches to improve
childhood blood lead testing rates.
Agenda items are subject to change as
priorities dictate.
Public Participation
Oral Public Comment: The public
comment period is scheduled on May
12, 2022, from 12:00 p.m. until 12:15
p.m., EDT. Individuals wishing to make
a comment during the public comment
period, please email your name,
organization, and phone number by
April 28, 2022, to LEPAC@cdc.gov.
The Director, Strategic Business
Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease
Control and Prevention, has been
delegated the authority to sign Federal
Register notices pertaining to
announcements of meetings and other
committee management activities, for
both the Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit,
Office of the Chief Operating Officer, Centers
for Disease Control and Prevention.
[FR Doc. 2022–05801 Filed 3–18–22; 8:45 am]
BILLING CODE 4163–18–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Medicare & Medicaid
Services
[CMS–3416–FN]
Medicare and Medicaid Programs;
Continued Approval of the American
Association for Accreditation of
Ambulatory Surgery Facilities’ Rural
Health Clinic Accreditation Program
Centers for Medicare &
Medicaid Services, Department of
Health and Human Services (HHS).
ACTION: Final notice.
AGENCY:
This final notice announces
our decision to approve the American
Association for Accreditation of
SUMMARY:
PO 00000
Frm 00096
Fmt 4703
Sfmt 4703
16003
Ambulatory Surgery Facilities
(AAAASF) for continued recognition as
a national accrediting organization for
Rural Health Clinics (RHCs) that wish to
participate in the Medicare or Medicaid
programs.
DATES: The decision in this final notice
is effective March 23, 2022, through
March 23, 2026.
FOR FURTHER INFORMATION CONTACT:
Lillian Williams, (410) 786–8636, or
Shonte Carter, (410) 786–3532.
SUPPLEMENTARY INFORMATION:
I. Background
A healthcare provider may enter into
an agreement with Medicare to
participate in the program as a Rural
Health Clinic (RHC) provided certain
requirements are met. Section
1861(aa)(2) and 1905(l)(1)of the Social
Security Act (the Act), establish distinct
criteria for facilities seeking designation
as RHCs for Medicare and Medicaid,
respectively. Regulations concerning
Medicare provider agreements are at 42
CFR part 489 and those pertaining to the
survey and certification for Medicare
participation of certain providers and
suppliers are at 42 CFR part 488. The
regulations at 42 CFR part 491 specify
the conditions that a facility must meet
to participate in the Medicare program
as an RHC.
Generally, to enter into a Medicare
provider agreement, an RHC must first
be certified by a State survey agency as
complying with the conditions set forth
in part 491 of our Medicare regulations.
Thereafter, the RHC is subject to
periodic surveys by a State survey
agency to determine whether it
continues to meet these conditions.
However, there is an alternative to
certification surveys by State agencies.
Accreditation by an approved,
nationally recognized Medicare
accreditation program may substitute for
both initial and ongoing review.
Section 1865(a)(1) of the Act provides
that, if the Secretary of the Department
of Health and Human Services finds that
accreditation of a provider entity by an
approved national accreditation
organization demonstrates that all
applicable Medicare conditions or
requirements are met or exceeded, we
will deem those provider entities as
having met such requirements.
Accreditation by an accrediting
organization is voluntary and is not
required for Medicare participation.
Subpart A of part 488 requires in part
that a national accrediting organization
applying for approval of its Medicare
accreditation program provide us with
reasonable assurance that the
accrediting organization requires its
E:\FR\FM\21MRN1.SGM
21MRN1
]]>Agencies
[Federal Register Volume 87, Number 54 (Monday, March 21, 2022)]
[Notices]
[Page 16003]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-05801]
[[Page 16003]]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
Lead Exposure and Prevention Advisory Committee (LEPAC)
AGENCY: Centers for Disease Control and Prevention (CDC), Department of
Health and Human Services (HHS).
ACTION: Notice of meeting.
-----------------------------------------------------------------------
SUMMARY: In accordance with the Federal Advisory Committee Act, the CDC
announces the following meeting for the Lead Exposure and Prevention
Advisory Committee (LEPAC). This is a virtual meeting and is open to
the public. Advance registration by April 28, 2022, is needed to
receive the information to join the meeting. The registration link is
provided in the addresses section below.
DATES: The meeting will be held on May 12, 2022, from 9:00 a.m. to 4:30
p.m., EDT.
ADDRESSES: Register in advance at https://www.zoomgov.com/webinar/register/WN_JpapSgFXRKmeHVU9hW4jVQ to receive information to join the
meeting.
FOR FURTHER INFORMATION CONTACT: Alexis Pullia, M.P.H., C.P.H.,
Committee Management Specialist, National Center for Environmental
Health, CDC, 4770 Buford Highway, Atlanta, Georgia 30341, Telephone:
770-488-3300; Email: [email protected].
SUPPLEMENTARY INFORMATION:
Background: The Lead Exposure and Prevention Advisory Committee was
established under Section 2203 of Public Law 114-322, the Water
Infrastructure Improvements for the Nation Act; 42 U.S.C. 300j-21,
Registry for Lead Exposure and Prevention Advisory Committee.
Purpose: The LEPAC is charged with providing advice and guidance to
the Secretary, Department of Health and Human Services (HHS), and the
Director, CDC and Administrator, ATSDR, on (1) reviewing Federal
programs and services available to individual communities exposed to
lead; (2) reviewing current research on lead exposure to identify
additional research needs; (3) reviewing and identifying best
practices, or the need for best practices regarding lead screening and
the prevention of lead poisoning; (4) identifying effective services,
including services relating to healthcare, education, and nutrition for
individuals and communities affected by lead exposure and lead
poisoning, including in consultation with, as appropriate, the lead
exposure registry as established in Section 2203(b) of Public Law 114-
322; and 5) undertaking any other review or activities that the
Secretary determines to be appropriate.
Matters To Be Considered: The agenda will include updates on the
Flint Lead Registry and lead-related activities from LEPAC Members;
information on lead exposure in Clarksburg, West Virginia; and
discussions on the following: Infrastructure initiatives related to
lead; lead in air, soil, and blood; navigating multiple funding streams
at the local level; and policy approaches to improve childhood blood
lead testing rates. Agenda items are subject to change as priorities
dictate.
Public Participation
Oral Public Comment: The public comment period is scheduled on May
12, 2022, from 12:00 p.m. until 12:15 p.m., EDT. Individuals wishing to
make a comment during the public comment period, please email your
name, organization, and phone number by April 28, 2022, to
[email protected].
The Director, Strategic Business Initiatives Unit, Office of the
Chief Operating Officer, Centers for Disease Control and Prevention,
has been delegated the authority to sign Federal Register notices
pertaining to announcements of meetings and other committee management
activities, for both the Centers for Disease Control and Prevention and
the Agency for Toxic Substances and Disease Registry.
Kalwant Smagh,
Director, Strategic Business Initiatives Unit, Office of the Chief
Operating Officer, Centers for Disease Control and Prevention.
[FR Doc. 2022-05801 Filed 3-18-22; 8:45 am]
BILLING CODE 4163-18-P
